The companies plan to combine Qiagen's sample technologies with 10x's microfluidics-based linked-read sequencing systems.
In a paper published today in Nature Methods, the researchers applied scM&T-seq to profile the transcriptomes and epigenomes of mouse embryonic stem cells.
By coupling a microfluidic platform and RNA sequencing, researchers found that single cells belonging to the same lineage have similar transcriptomic profiles.
The method, developed by researchers at the NIH and their colleagues, could be useful to analyze rare cell populations and clinical samples with very small numbers of cells.
During the quarter the firm launched its ICell8 Single Cell System and made a public offering of stock that raised $17.3 million.
The company reported preliminary Q3 revenue growth of between 52 percent and 68 percent, and raised its revenue guidance for full-year 2015.
The public-private consortium aims to develop and disseminate stem cell-based technologies and assays to study autism spectrum disorder and other mental health diseases.
The microcapillary-based single-cell platform is designed to analyze antibodies but could be used to detect other cell products.
Researchers found that around 13 percent of CLL patients contain at least one partner clone, although the clinical significance of the finding is still unclear.
BD plans to launch a cell sorter for the genomics market over the next six months and to release an automated NGS library prep system in early 2016.
The Wall Street Journal looks into FamilyTreeDNA's handling of genetic genealogy searches by law enforcement.
In a point-counterpoint in the Boston Globe, researchers discuss the potential of gene editing to prevent Lyme disease, but also the pitfalls of doing so.
MIT's Technology Review reports that researchers hope to develop a CRISPR-based pain therapy.
In Science this week: atlas of malaria parasites' gene expression across their life cycles, and more.